secwatch.observer — SEC 8-K summary
======================================

Issuer:     biote Corp. (BTMD)
CIK:        0001819253
Form:       8-K
Filed at:   2026-08-05T20:20:16+00:00
Accession:  0001193125-26-335200
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biote Q2 2026 revenue $44.2M (-9.5% YoY); net loss $(7.4)M vs net income $3.9M; updates full-year outlook
--------------------------------------------------------------------------------

- Revenue $44.2M (-9.5% YoY); procedure revenue $30.3M (-13.9%) due to voluntary recall of Asteria Health pellets.
- Net loss $(7.4)M ($0.23 diluted loss per share) vs net income $3.9M ($0.10 EPS) in Q2 2025.
- Adjusted EBITDA $5.6M (12.6% margin); gross margin 65.4% vs 71.6% due to recall costs.
- Dietary supplements revenue grew 5.7% to $11.4M.
- Company updated full-year 2026 outlook; specifics not provided in excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819253/000119312526335200/0001193125-26-335200-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819253/000119312526335200/btmd-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-335200

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer